000			01921 a2200493 4500
005			20250517024125.0
264		0	_c20160208
008			201602s 0 0 eng d
022			_a1365-2362
024	7		_a10.1111/eci.12441 _2doi
040			_aNLM _beng _cNLM
100	1		_aDelire, Bénédicte
245	0	0	_aThe Ras/MAPK pathway and hepatocarcinoma: pathogenesis and therapeutic implications. _h[electronic resource]
260			_bEuropean journal of clinical investigation _cJun 2015
300			_a609-23 p. _bdigital
500			_aPublication Type: Journal Article; Review
650	0	4	_aAdaptor Proteins, Signal Transducing
650	0	4	_aAnimals
650	0	4	_aAntineoplastic Agents _xtherapeutic use
650	0	4	_aApoptosis Regulatory Proteins
650	0	4	_aCarcinogenesis _xmetabolism
650	0	4	_aCarcinoma, Hepatocellular _xdrug therapy
650	0	4	_aHumans
650	0	4	_aIntracellular Signaling Peptides and Proteins _xphysiology
650	0	4	_aLiver Neoplasms _xdrug therapy
650	0	4	_aMAP Kinase Signaling System _xphysiology
650	0	4	_aMembrane Proteins _xphysiology
650	0	4	_aMice
650	0	4	_aMitogen-Activated Protein Kinases _xmetabolism
650	0	4	_aMonomeric GTP-Binding Proteins _xphysiology
650	0	4	_aMutation _xgenetics
650	0	4	_aNiacinamide _xanalogs & derivatives
650	0	4	_aPhenylurea Compounds _xtherapeutic use
650	0	4	_aProtein Kinase Inhibitors _xtherapeutic use
650	0	4	_aRats
650	0	4	_aSorafenib
650	0	4	_aTumor Suppressor Proteins _xphysiology
650	0	4	_araf Kinases _xmetabolism
650	0	4	_aras GTPase-Activating Proteins _xantagonists & inhibitors
650	0	4	_aras Proteins _xantagonists & inhibitors
700	1		_aStärkel, Peter
773	0		_tEuropean journal of clinical investigation _gvol. 45 _gno. 6 _gp. 609-23
856	4	0	_uhttps://doi.org/10.1111/eci.12441 _zAvailable from publisher's website
999			_c24765147 _d24765147